Antineoplastic activity of three ruthenium derivatives against chemically induced colorectal carcinoma in rats View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1992-03

AUTHORS

Matthias H. Seelig, Martin R. Berger, Bernhard K. Keppler

ABSTRACT

The antineoplastic activity of the ruthenium complexestrans-imidazolium[tetrachlorobisimidazoleruthenate(III)], HIm(RuIm2Cl4),trans-indazolium-[tetrachlorobis(1H-indazole)ruthenate(III,N2)], HInd [RuInd2Cl4(N2)], andtrans-indazolium[tetrachlorobis(2H-indazole)ruthenate(III,N1)], HInd[RuInd2Cl4-(N1)] was assessed in acetoxymethylmethylnitrosamine-induced autochthonous colorectal carcinomas of Sprague-Dawley rats. The model is not sensitive to clinically established antineoplastic agents, including cisplatin. An exception is the combination therapy with 5-fluorouracil/leucovorin, which shows moderate activity against the tumour model. In contrast to this general trend, the new substances were all active against this tumour. HIm(RuIm2Cl4) was very effective at all dosages applied (7.5 mg/kg, 5.3 mg/kg, and 3.8 mg/kg), as indicated by percentage treated/control (T/C values of 23%, 34.5%, and 44%. Toxicity was considerable as shown by a body weight change of −30%, −19%, and −9%. Nevertheless, the medium dose seems to be the optimum in terms of mortality (0% vs 15% in the control group), whereas at the highest dose, mortality increased as a result of substance toxicity, and at the lowest dose mortality increased through tumor growth combined with substance toxicity.HInd[RuInd2Cl4(N2)] showed high efficacy at the highest dosage of 13 mg/kg, reaching a T/C value of 27% combined with 0% mortality versus 15% in the control group. In equimolar dosages (10 mg/kg, 7.1 mg/kg and 5.1 mg/kg), the compound is not as active as HIm-(RuIm2Cl4), as indicated by T/C values of 50.2%, 45.7%, and 38.6%. HInd[RuInd2Cl4(N1)] was slightly but not significantly better than HInd[RuInd2Cl4(N2)] at a dosage of 7.1 mg/kg and is advantageous over combination therapy with 5-fluorouracil and leucovorin (20/20 mg/kg) in terms of efficacy (T/C=37.6% versus 44.7%) and mortality (6% versus 33.3%). More... »

PAGES

195-200

References to SciGraph publications

  • 1987-07. Comparative antitumor activity of ruthenium derivatives with 5′-deoxy-5-fluorouridine in chemically induced colorectal tumors in SD rats in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1983-01. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato)titanium(IV) compounds in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 1989. New Ruthenium Complexes for the Treatment of Cancer in RUTHENIUM AND OTHER NON-PLATINUM METAL COMPLEXES IN CANCER CHEMOTHERAPY
  • 1986. Maligne Tumoren des Kolons in CHIRURGISCHE ONKOLOGIE
  • 1975-10. Evaluation of endoscopic examination of colon tumors in rats in DIGESTIVE DISEASES AND SCIENCES
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/bf01410134

    DOI

    http://dx.doi.org/10.1007/bf01410134

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1053560513

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/1548284


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Pharmacology and Pharmaceutical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Body Weight", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Carcinoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Colorectal Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dose-Response Relationship, Drug", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Imidazoles", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Indazoles", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Organometallic Compounds", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rats", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rats, Inbred Strains", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Ruthenium", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, W-6900, Heidelberg, Germany", 
              "id": "http://www.grid.ac/institutes/grid.7497.d", 
              "name": [
                "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, W-6900, Heidelberg, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Seelig", 
            "givenName": "Matthias H.", 
            "id": "sg:person.01062355255.01", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062355255.01"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, W-6900, Heidelberg, Germany", 
              "id": "http://www.grid.ac/institutes/grid.7497.d", 
              "name": [
                "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, W-6900, Heidelberg, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Berger", 
            "givenName": "Martin R.", 
            "id": "sg:person.01256203524.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256203524.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institute of Inorganic Chemistry, University of Heidelberg, Im Neuenheimer Feld 270, W-6900, Heidelberg, Germany", 
              "id": "http://www.grid.ac/institutes/grid.7700.0", 
              "name": [
                "Institute of Inorganic Chemistry, University of Heidelberg, Im Neuenheimer Feld 270, W-6900, Heidelberg, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Keppler", 
            "givenName": "Bernhard K.", 
            "id": "sg:person.0606573400.82", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606573400.82"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/bf00261487", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020513223", 
              "https://doi.org/10.1007/bf00261487"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01070878", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048388310", 
              "https://doi.org/10.1007/bf01070878"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-3-642-69600-8_28", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020422047", 
              "https://doi.org/10.1007/978-3-642-69600-8_28"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-3-642-74760-1_3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000987926", 
              "https://doi.org/10.1007/978-3-642-74760-1_3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00391842", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048398971", 
              "https://doi.org/10.1007/bf00391842"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1992-03", 
        "datePublishedReg": "1992-03-01", 
        "description": "The antineoplastic activity of the ruthenium complexestrans-imidazolium[tetrachlorobisimidazoleruthenate(III)], HIm(RuIm2Cl4),trans-indazolium-[tetrachlorobis(1H-indazole)ruthenate(III,N2)], HInd [RuInd2Cl4(N2)], andtrans-indazolium[tetrachlorobis(2H-indazole)ruthenate(III,N1)], HInd[RuInd2Cl4-(N1)] was assessed in acetoxymethylmethylnitrosamine-induced autochthonous colorectal carcinomas of Sprague-Dawley rats. The model is not sensitive to clinically established antineoplastic agents, including cisplatin. An exception is the combination therapy with 5-fluorouracil/leucovorin, which shows moderate activity against the tumour model. In contrast to this general trend, the new substances were all active against this tumour. HIm(RuIm2Cl4) was very effective at all dosages applied (7.5 mg/kg, 5.3 mg/kg, and 3.8 mg/kg), as indicated by percentage treated/control (T/C values of 23%, 34.5%, and 44%. Toxicity was considerable as shown by a body weight change of \u221230%, \u221219%, and \u22129%. Nevertheless, the medium dose seems to be the optimum in terms of mortality (0% vs 15% in the control group), whereas at the highest dose, mortality increased as a result of substance toxicity, and at the lowest dose mortality increased through tumor growth combined with substance toxicity.HInd[RuInd2Cl4(N2)] showed high efficacy at the highest dosage of 13 mg/kg, reaching a T/C value of 27% combined with 0% mortality versus 15% in the control group. In equimolar dosages (10 mg/kg, 7.1 mg/kg and 5.1 mg/kg), the compound is not as active as HIm-(RuIm2Cl4), as indicated by T/C values of 50.2%, 45.7%, and 38.6%. HInd[RuInd2Cl4(N1)] was slightly but not significantly better than HInd[RuInd2Cl4(N2)] at a dosage of 7.1 mg/kg and is advantageous over combination therapy with 5-fluorouracil and leucovorin (20/20 mg/kg) in terms of efficacy (T/C=37.6% versus 44.7%) and mortality (6% versus 33.3%).", 
        "genre": "article", 
        "id": "sg:pub.10.1007/bf01410134", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1313647", 
            "issn": [
              "0171-5216", 
              "1432-1335"
            ], 
            "name": "Journal of Cancer Research and Clinical Oncology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "3", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "118"
          }
        ], 
        "keywords": [
          "Sprague-Dawley rats", 
          "combination therapy", 
          "colorectal carcinoma", 
          "tumor model", 
          "antineoplastic agents", 
          "antineoplastic activity", 
          "moderate activity", 
          "leucovorin", 
          "new substances", 
          "carcinoma", 
          "therapy", 
          "tumors", 
          "rats", 
          "cisplatin", 
          "hind", 
          "activity", 
          "dosage", 
          "agents", 
          "percentage", 
          "control", 
          "substances", 
          "contrast", 
          "exception", 
          "model", 
          "trends", 
          "indazolium", 
          "general trend", 
          "andtrans"
        ], 
        "name": "Antineoplastic activity of three ruthenium derivatives against chemically induced colorectal carcinoma in rats", 
        "pagination": "195-200", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1053560513"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/bf01410134"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "1548284"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/bf01410134", 
          "https://app.dimensions.ai/details/publication/pub.1053560513"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-08-04T16:51", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_235.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/bf01410134"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf01410134'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf01410134'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf01410134'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf01410134'


     

    This table displays all metadata directly associated to this object as RDF triples.

    178 TRIPLES      21 PREDICATES      72 URIs      59 LITERALS      20 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/bf01410134 schema:about N0e3aeb06004e4342a14edc29ef439811
    2 N0faf72cbd6384c8cbc2a9dd61a49d243
    3 N1029e1ab835c4ca79a973d055b3844f0
    4 N31d3b6ac619c4a2ba9c4ef089db51428
    5 N35bd01e1f97441b8b91f860d997719b9
    6 Na330608d10874f83a65aa1bd1e80bbb6
    7 Nc659ab1a99984d8aa8fa8eda6fbb4f20
    8 Ncf392a870aaa428ba9f1df0d37c06c60
    9 Nd432f97f13844af492822c6d58a4fe8b
    10 Nd9a439d48d3e45c0a6697cf363a8b3e5
    11 Nebb9fcf787a94e278ef82ea60f8cf931
    12 Nedd51438cf624000a2a6ed74590d274f
    13 Nf5bafc73d81e4bc489a238add73391f8
    14 anzsrc-for:11
    15 anzsrc-for:1115
    16 schema:author N29fbf5344b084ccc9f880cb670405177
    17 schema:citation sg:pub.10.1007/978-3-642-69600-8_28
    18 sg:pub.10.1007/978-3-642-74760-1_3
    19 sg:pub.10.1007/bf00261487
    20 sg:pub.10.1007/bf00391842
    21 sg:pub.10.1007/bf01070878
    22 schema:datePublished 1992-03
    23 schema:datePublishedReg 1992-03-01
    24 schema:description The antineoplastic activity of the ruthenium complexestrans-imidazolium[tetrachlorobisimidazoleruthenate(III)], HIm(RuIm2Cl4),trans-indazolium-[tetrachlorobis(1H-indazole)ruthenate(III,N2)], HInd [RuInd2Cl4(N2)], andtrans-indazolium[tetrachlorobis(2H-indazole)ruthenate(III,N1)], HInd[RuInd2Cl4-(N1)] was assessed in acetoxymethylmethylnitrosamine-induced autochthonous colorectal carcinomas of Sprague-Dawley rats. The model is not sensitive to clinically established antineoplastic agents, including cisplatin. An exception is the combination therapy with 5-fluorouracil/leucovorin, which shows moderate activity against the tumour model. In contrast to this general trend, the new substances were all active against this tumour. HIm(RuIm2Cl4) was very effective at all dosages applied (7.5 mg/kg, 5.3 mg/kg, and 3.8 mg/kg), as indicated by percentage treated/control (T/C values of 23%, 34.5%, and 44%. Toxicity was considerable as shown by a body weight change of −30%, −19%, and −9%. Nevertheless, the medium dose seems to be the optimum in terms of mortality (0% vs 15% in the control group), whereas at the highest dose, mortality increased as a result of substance toxicity, and at the lowest dose mortality increased through tumor growth combined with substance toxicity.HInd[RuInd2Cl4(N2)] showed high efficacy at the highest dosage of 13 mg/kg, reaching a T/C value of 27% combined with 0% mortality versus 15% in the control group. In equimolar dosages (10 mg/kg, 7.1 mg/kg and 5.1 mg/kg), the compound is not as active as HIm-(RuIm2Cl4), as indicated by T/C values of 50.2%, 45.7%, and 38.6%. HInd[RuInd2Cl4(N1)] was slightly but not significantly better than HInd[RuInd2Cl4(N2)] at a dosage of 7.1 mg/kg and is advantageous over combination therapy with 5-fluorouracil and leucovorin (20/20 mg/kg) in terms of efficacy (T/C=37.6% versus 44.7%) and mortality (6% versus 33.3%).
    25 schema:genre article
    26 schema:isAccessibleForFree false
    27 schema:isPartOf N091b50a1006148da814cc86a9ad42748
    28 N570fd336c2d74e4583a13436baaab89a
    29 sg:journal.1313647
    30 schema:keywords Sprague-Dawley rats
    31 activity
    32 agents
    33 andtrans
    34 antineoplastic activity
    35 antineoplastic agents
    36 carcinoma
    37 cisplatin
    38 colorectal carcinoma
    39 combination therapy
    40 contrast
    41 control
    42 dosage
    43 exception
    44 general trend
    45 hind
    46 indazolium
    47 leucovorin
    48 model
    49 moderate activity
    50 new substances
    51 percentage
    52 rats
    53 substances
    54 therapy
    55 trends
    56 tumor model
    57 tumors
    58 schema:name Antineoplastic activity of three ruthenium derivatives against chemically induced colorectal carcinoma in rats
    59 schema:pagination 195-200
    60 schema:productId N22917565c20549db96a217139908d3bd
    61 Na4c7a484504a4f8d8a9ac70209cc221f
    62 Nd1eda43b8a964adc85501a612de92c5c
    63 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053560513
    64 https://doi.org/10.1007/bf01410134
    65 schema:sdDatePublished 2022-08-04T16:51
    66 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    67 schema:sdPublisher N53ab57cd8ca7441299aaca7699105dc4
    68 schema:url https://doi.org/10.1007/bf01410134
    69 sgo:license sg:explorer/license/
    70 sgo:sdDataset articles
    71 rdf:type schema:ScholarlyArticle
    72 N091b50a1006148da814cc86a9ad42748 schema:issueNumber 3
    73 rdf:type schema:PublicationIssue
    74 N0e3aeb06004e4342a14edc29ef439811 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    75 schema:name Colorectal Neoplasms
    76 rdf:type schema:DefinedTerm
    77 N0faf72cbd6384c8cbc2a9dd61a49d243 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    78 schema:name Antineoplastic Agents
    79 rdf:type schema:DefinedTerm
    80 N1029e1ab835c4ca79a973d055b3844f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    81 schema:name Rats
    82 rdf:type schema:DefinedTerm
    83 N22917565c20549db96a217139908d3bd schema:name doi
    84 schema:value 10.1007/bf01410134
    85 rdf:type schema:PropertyValue
    86 N29fbf5344b084ccc9f880cb670405177 rdf:first sg:person.01062355255.01
    87 rdf:rest N939b8d917d214a38a6dd593ba1331eb5
    88 N31d3b6ac619c4a2ba9c4ef089db51428 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    89 schema:name Rats, Inbred Strains
    90 rdf:type schema:DefinedTerm
    91 N35bd01e1f97441b8b91f860d997719b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    92 schema:name Dose-Response Relationship, Drug
    93 rdf:type schema:DefinedTerm
    94 N53ab57cd8ca7441299aaca7699105dc4 schema:name Springer Nature - SN SciGraph project
    95 rdf:type schema:Organization
    96 N570fd336c2d74e4583a13436baaab89a schema:volumeNumber 118
    97 rdf:type schema:PublicationVolume
    98 N939b8d917d214a38a6dd593ba1331eb5 rdf:first sg:person.01256203524.22
    99 rdf:rest N98a6d73c2a9b4d5a935b728e0b144180
    100 N98a6d73c2a9b4d5a935b728e0b144180 rdf:first sg:person.0606573400.82
    101 rdf:rest rdf:nil
    102 Na330608d10874f83a65aa1bd1e80bbb6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    103 schema:name Ruthenium
    104 rdf:type schema:DefinedTerm
    105 Na4c7a484504a4f8d8a9ac70209cc221f schema:name dimensions_id
    106 schema:value pub.1053560513
    107 rdf:type schema:PropertyValue
    108 Nc659ab1a99984d8aa8fa8eda6fbb4f20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    109 schema:name Carcinoma
    110 rdf:type schema:DefinedTerm
    111 Ncf392a870aaa428ba9f1df0d37c06c60 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    112 schema:name Organometallic Compounds
    113 rdf:type schema:DefinedTerm
    114 Nd1eda43b8a964adc85501a612de92c5c schema:name pubmed_id
    115 schema:value 1548284
    116 rdf:type schema:PropertyValue
    117 Nd432f97f13844af492822c6d58a4fe8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    118 schema:name Male
    119 rdf:type schema:DefinedTerm
    120 Nd9a439d48d3e45c0a6697cf363a8b3e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    121 schema:name Body Weight
    122 rdf:type schema:DefinedTerm
    123 Nebb9fcf787a94e278ef82ea60f8cf931 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    124 schema:name Animals
    125 rdf:type schema:DefinedTerm
    126 Nedd51438cf624000a2a6ed74590d274f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    127 schema:name Indazoles
    128 rdf:type schema:DefinedTerm
    129 Nf5bafc73d81e4bc489a238add73391f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    130 schema:name Imidazoles
    131 rdf:type schema:DefinedTerm
    132 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    133 schema:name Medical and Health Sciences
    134 rdf:type schema:DefinedTerm
    135 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
    136 schema:name Pharmacology and Pharmaceutical Sciences
    137 rdf:type schema:DefinedTerm
    138 sg:journal.1313647 schema:issn 0171-5216
    139 1432-1335
    140 schema:name Journal of Cancer Research and Clinical Oncology
    141 schema:publisher Springer Nature
    142 rdf:type schema:Periodical
    143 sg:person.01062355255.01 schema:affiliation grid-institutes:grid.7497.d
    144 schema:familyName Seelig
    145 schema:givenName Matthias H.
    146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062355255.01
    147 rdf:type schema:Person
    148 sg:person.01256203524.22 schema:affiliation grid-institutes:grid.7497.d
    149 schema:familyName Berger
    150 schema:givenName Martin R.
    151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256203524.22
    152 rdf:type schema:Person
    153 sg:person.0606573400.82 schema:affiliation grid-institutes:grid.7700.0
    154 schema:familyName Keppler
    155 schema:givenName Bernhard K.
    156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606573400.82
    157 rdf:type schema:Person
    158 sg:pub.10.1007/978-3-642-69600-8_28 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020422047
    159 https://doi.org/10.1007/978-3-642-69600-8_28
    160 rdf:type schema:CreativeWork
    161 sg:pub.10.1007/978-3-642-74760-1_3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000987926
    162 https://doi.org/10.1007/978-3-642-74760-1_3
    163 rdf:type schema:CreativeWork
    164 sg:pub.10.1007/bf00261487 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020513223
    165 https://doi.org/10.1007/bf00261487
    166 rdf:type schema:CreativeWork
    167 sg:pub.10.1007/bf00391842 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048398971
    168 https://doi.org/10.1007/bf00391842
    169 rdf:type schema:CreativeWork
    170 sg:pub.10.1007/bf01070878 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048388310
    171 https://doi.org/10.1007/bf01070878
    172 rdf:type schema:CreativeWork
    173 grid-institutes:grid.7497.d schema:alternateName Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, W-6900, Heidelberg, Germany
    174 schema:name Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, W-6900, Heidelberg, Germany
    175 rdf:type schema:Organization
    176 grid-institutes:grid.7700.0 schema:alternateName Institute of Inorganic Chemistry, University of Heidelberg, Im Neuenheimer Feld 270, W-6900, Heidelberg, Germany
    177 schema:name Institute of Inorganic Chemistry, University of Heidelberg, Im Neuenheimer Feld 270, W-6900, Heidelberg, Germany
    178 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...